FOI release

Marketing Authorisation Holder: Dawa Ltd

This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00949

Received 25 August 2026

Published 6 November 2026

Request

Thank you for your response regarding FOI requests FOI2026/00814 and FOI2026/00815. In accordance with your request to reduce the scope of the FOI request, I confirm that I would like to proceed with FOI2026/00815 only, relating to the following Marketing Authorisation: Marketing Authorisation Holder: Dawa Ltd Product: Cyanocobalamin 50 microgram Film-coated Tablets PL Number: 30684/0243 FOI Reference: FOI2026/00815 The information requested remains limited to Module 2.4, Module 2.5 and Module 2.7 submitted in support of the above Marketing Authorisation. Please proceed with the processing of FOI2026/00815 on this reduced scope. Thank you for your assistance.

Response

See attached

Documents

• clinical-overview_Redacted.pdf (5.8 MB)
• FOI2026_00949 (redacted).pdf (715.6 KB)
• nonclinical-overview_Redacted.pdf (3.3 MB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.